Your browser doesn't support javascript.
loading
CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
Nakae, Ruriko; Matsuzaki, Shinya; Serada, Satoshi; Matsuo, Koji; Shiomi, Mayu; Sato, Kazuaki; Nagase, Yoshikazu; Matsuzaki, Satoko; Nakagawa, Satoshi; Hiramatsu, Kosuke; Okazawa, Akiko; Kimura, Toshihiro; Egawa-Takata, Tomomi; Kobayashi, Eiji; Ueda, Yutaka; Yoshino, Kiyoshi; Naka, Tetsuji; Kimura, Tadashi.
Afiliação
  • Nakae R; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan; Department of Obstetrics and Gynecology, Sumitomo Hospital, Osaka, Japan.
  • Matsuzaki S; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA. Electronic address: zacky@gyne.med.osaka-u.ac.jp.
  • Serada S; Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Kochi, Japan. Electronic address: serada@kochi-u.ac.jp.
  • Matsuo K; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.
  • Shiomi M; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
  • Sato K; Department of Pathology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Nagase Y; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
  • Matsuzaki S; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA; Department of Obstetrics and Gynecology, Otemae Hospital, Osaka, Japan.
  • Nakagawa S; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
  • Hiramatsu K; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
  • Okazawa A; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
  • Kimura T; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
  • Egawa-Takata T; Department of Obstetrics and Gynecology, Osaka Police Hospital, Osaka, Japan; Department of Obstetrics and Gynecology, Kansai Rosai Hospital, Amagasaki, Japan.
  • Kobayashi E; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
  • Ueda Y; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
  • Yoshino K; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan; Department of Obstetrics and Gynecology, University of Occupational and Environmental Health, Fukuoka, Japan.
  • Naka T; Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Kochi, Japan.
  • Kimura T; Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
Am J Obstet Gynecol ; 224(2): 197.e1-197.e23, 2021 02.
Article em En | MEDLINE | ID: mdl-32822640

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias Uterinas / Imunoconjugados / Proliferação de Células / Ligante CD27 / Leiomiossarcoma / Anticorpos Monoclonais / Miométrio Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Middle aged Idioma: En Revista: Am J Obstet Gynecol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias Uterinas / Imunoconjugados / Proliferação de Células / Ligante CD27 / Leiomiossarcoma / Anticorpos Monoclonais / Miométrio Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Middle aged Idioma: En Revista: Am J Obstet Gynecol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos